UCB selects Georgia for $2B first U.S. biologics plant

UCB selected the Rowen development near Dacula for a 460,000-square-foot biologics manufacturing campus. The company's first U.S. manufacturing facility is expected to create about 330 permanent jobs and use automation, robotics, and AI across production.